| __timestamp | Jazz Pharmaceuticals plc | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 117418000 | 520990000000 |
| Thursday, January 1, 2015 | 102526000 | 535405000000 |
| Friday, January 1, 2016 | 105386000 | 558755000000 |
| Sunday, January 1, 2017 | 110188000 | 495921000000 |
| Monday, January 1, 2018 | 121544000 | 659690000000 |
| Tuesday, January 1, 2019 | 127930000 | 1089764000000 |
| Wednesday, January 1, 2020 | 148917000 | 994308000000 |
| Friday, January 1, 2021 | 440760000 | 1106846000000 |
| Saturday, January 1, 2022 | 540517000 | 1244072000000 |
| Sunday, January 1, 2023 | 435577000 | 1431505000000 |
| Monday, January 1, 2024 | 1431505000000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals, cost efficiency is a critical factor for success. This analysis compares the cost of revenue efficiency between Takeda Pharmaceutical Company Limited and Jazz Pharmaceuticals plc from 2014 to 2023. Over this period, Takeda consistently demonstrated a robust cost structure, with its cost of revenue peaking at approximately 1.43 trillion in 2023, marking a 174% increase from 2014. In contrast, Jazz Pharmaceuticals showed a more volatile trend, with a significant spike in 2022, reaching a cost of revenue that was nearly five times its 2014 value. This fluctuation highlights the challenges smaller pharmaceutical companies face in maintaining cost efficiency. Notably, data for Jazz Pharmaceuticals in 2024 is missing, indicating potential reporting gaps. As the pharmaceutical landscape evolves, these insights underscore the importance of strategic financial management in sustaining growth and competitiveness.
Analyzing Cost of Revenue: Merck & Co., Inc. and Takeda Pharmaceutical Company Limited
GSK plc vs Jazz Pharmaceuticals plc: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Takeda Pharmaceutical Company Limited vs Perrigo Company plc
Cost Insights: Breaking Down Takeda Pharmaceutical Company Limited and HUTCHMED (China) Limited's Expenses
Analyzing Cost of Revenue: Takeda Pharmaceutical Company Limited and Wave Life Sciences Ltd.
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Travere Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Xencor, Inc.
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs BioCryst Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Viridian Therapeutics, Inc.
Cost of Revenue: Key Insights for Jazz Pharmaceuticals plc and Amneal Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Jazz Pharmaceuticals plc and Mesoblast Limited
Cost Insights: Breaking Down Jazz Pharmaceuticals plc and MiMedx Group, Inc.'s Expenses